- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
VIA Pharmaceuticals Inc
+ Add to WatchlistVIAP:US
0.0035 USD 0.0015 30.00%As of 20:10:00 ET on 06/13/2013.
Snapshot for VIA Pharmaceuticals Inc (VIAP)
| Open: | 0.0035 | Day's Range: | 0.0035 - 0.0035 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.0050 | 52wk Range: | 0.0033 - 0.0300 | 1-Yr Rtn: | -70.83% |
Key Statistics for VIAP
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2011) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.4600 |
| Est. EPS (12/2011) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.07 |
| Shares Outstanding (M) | 20.56 |
| 30 Day Average Volume | 5,582 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for VIAP
No data available
Company Profile & Key Executives for VIAP
VIA Pharmaceuticals Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. The Company is developing a pipeline of small-molecule drugs that target inflammation in the blood vessel wall, an underlying cause of atherosclerosis and its complications, including heart attack and stroke.
| Douglass B GivenChairman | Lawrence K CohenPresident/CEO |
| Rebecca A TaubSenior VP:Research & Dev | Karen S WrightVP/Controller |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
VIAP News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page